Mariko Kasai, Hiroshi Sakuma, Yuichi Abe, Ichiro Kuki, Yoshihiro Maegaki, Kei Murayama, Yuka Murofushi, Hiroaki Nagase, Masahiro Nishiyama, Akihisa Okumura, et al. Clinical characteristics of SARS-CoV-2-associated encephalopathy in children: Nationwide epidemiological study. Journal of the neurological sciences. 2024. 457. 122867-122867
Masahiro Nishiyama, Yuki Kyono, Hiroshi Yamaguchi, Aoi Kawamura, Shizuka Oikawa, Shoichi Tokumoto, Kazumi Tomioka, Kandai Nozu, Hiroaki Nagase. Association of early bedtime at 3 years of age with higher academic performance and better non-cognitive skills in elementary school. Scientific reports. 2023. 13. 1. 20926-20926
Hiroaki Hanafusa, Hiroshi Yamaguchi, Hidehito Kondo, Miwako Nagasaka, Ming Juan Ye, Shizuka Oikawa, Shoichi Tokumoto, Kazumi Tomioka, Masahiro Nishiyama, Naoya Morisada, et al. Dravet syndrome and hemorrhagic shock and encephalopathy syndrome associated with an intronic deletion of SCN1A. Brain & development. 2023. 45. 6. 317-323
Kazuki Segawa, Masahiro Nishiyama, Itsuki Mori, Tomoya Kubota, Masanori P Takahashi. Hyperkalemic periodic paralysis associated with a novel missense variant located in the inner pore of Nav1.4. Brain & development. 2023. 45. 4. 205-211
南部静紀, 粟野宏之, 洪聖媛, 徳元翔一, 山口宏, 坊亮輔, 冨岡和美, 西山将広, 篠原正和, 永瀬裕朗, et al. A SMA1 infant who received Zolgensma therapy at the age of 50 days. 日本小児科学会雑誌. 2021. 125. 2
日本小児精神神経学会
, American Epilepsy Society
, American Academy of Neurology
, Japan Epilepsy Society
, Japanese Society of Child Neurology
, Japan Pediatric Society